AI assistant
Sending…
Twist Bioscience Corp — Director's Dealing 2021
Apr 26, 2021
31873_dirs_2021-04-26_473b0fea-f552-4e85-a8d4-613323a527a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-04-22
Reporting Person: THORBURN JAMES M (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-22 | Common Stock | M | 5000 | $11.59 | Acquired | 53034 | Direct |
| 2021-04-22 | Common Stock | S | 5000 | $133.47 | Disposed | 48034 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-22 | Employee Stock Option (right to buy) | $11.59 | M | 5000 | Disposed | 2028-06-06 | Common Stock (5000) | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 16, 2020.
F2: The option is immediately exercisable. 25% of the shares subject to the option vested on April 23, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
More from Twist Bioscience Corp
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25